Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.

Publikation

Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.

Wissenschaftlicher Artikel/Review - 11.02.2023

Jensen Anders Boisen, Renström Frida, Aczel Stefan, Folie Patrick, Biraima Magdalena, Beuschlein Felix, Bilz Stefan

Zitation

Jensen A, Renström F, Aczel S, Folie P, Biraima M, Beuschlein F, Bilz S. Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study. Obes Surg 2023:1-9.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Obes Surg 2023

Veröffentlichungsdatum

11.02.2023

eISSN (Online)

1708-0428

Seiten

1-9

Kurzbeschreibung/Zielsetzung

Weight regain after bariatric surgery occurs in up to a third of patients and reduces treatment-associated health benefits. The efficacy of glucagon-like peptide-1 receptor agonists (GLP1-RA) for treatment of type 2 diabetes mellitus and obesity is well established, but their role in the treatment of weight regain after bariatric surgery remains to be defined.